Torigoe T, Millan J A, Chan K W, Taichman R, Brian A A, Reed J C, Tachman R [corrected to Taichman R ]
La Jolla Cancer Research Foundation, Cancer Research Center, California 92037.
J Exp Med. 1994 Sep 1;180(3):1115-27. doi: 10.1084/jem.180.3.1115.
Elevated levels of p56-Lck kinase activity were achieved in an interleukin 2 (IL-2)-dependent cloned cytolytic T cell CTLL-2 through gene transfer approaches. CTLL-2-Lck cells remained dependent on IL-2 for growth and survival in culture but exhibited markedly elevated, IL-2-independent cytolytic activity against a variety of tumor targets. This immune cell effector function was similar to the non-major histocompatibility complex-restricted cytolytic activity previously described for lymphokine activated killer (LAK) cells, and involved a cytolytic mechanism that was independent of protein synthesis in either the T cells or the tumor targets. Characterization of CTLL-2-Lck cells revealed markedly elevated levels of both the alpha (CD11a) and beta (CD18) chains of the cell adhesion molecule lymphocyte function-associated 1 (LFA-1) and increased binding of these T cells to a recombinant protein representing the extracellular domain of the LFA-ligand, intercellular adhesion molecule 1 (ICAM-1). Antibodies to CD11a partially abrogated cytolytic killing of tumor target cells by CTLL-2-Lck cells, suggesting that the upregulation in LFA protein levels potentially accounts at least in part for the phenotype of these T cells. Gene transfer-mediated elevations in p56-Lck kinase activity in an IL-3-dependent myeloid cell clone 32D.3 also resulted in increased LFA-1 expression, demonstrating that the findings are not unique to CTLL-2 cells. In addition to upregulation of LFA-1 expression, CTLL-Lck cells also exhibited more efficient exocytosis of cytotoxic granules upon activation with Ca(2+)-ionophore and phorbol ester, relative to control transfected and untransfected CTLL-2 cells. The findings functionally link the Lck kinase to a T cell effector pathway involved in cell-mediated cytotoxicity.
通过基因转移方法,在依赖白细胞介素2(IL-2)的克隆性细胞毒性T细胞CTLL-2中实现了p56-Lck激酶活性水平的升高。CTLL-2-Lck细胞在培养中生长和存活仍依赖IL-2,但对多种肿瘤靶标表现出明显升高的、不依赖IL-2的细胞毒性活性。这种免疫细胞效应功能类似于先前描述的淋巴因子激活的杀伤(LAK)细胞的非主要组织相容性复合体限制的细胞毒性活性,并且涉及一种与T细胞或肿瘤靶标中的蛋白质合成无关的细胞毒性机制。对CTLL-2-Lck细胞的表征显示,细胞粘附分子淋巴细胞功能相关抗原1(LFA-1)的α(CD11a)链和β(CD18)链水平均明显升高,并且这些T细胞与代表LFA配体细胞外结构域的重组蛋白细胞间粘附分子1(ICAM-1)的结合增加。抗CD11a抗体部分消除了CTLL-2-Lck细胞对肿瘤靶细胞的细胞毒性杀伤作用,表明LFA蛋白水平的上调可能至少部分解释了这些T细胞的表型。在依赖IL-3的髓样细胞克隆32D.3中,基因转移介导的p56-Lck激酶活性升高也导致LFA-1表达增加,表明这些发现并非CTLL-2细胞所特有。除了LFA-1表达上调外,相对于对照转染和未转染的CTLL-2细胞,CTLL-Lck细胞在用钙离子载体和佛波酯激活后还表现出更有效的细胞毒性颗粒胞吐作用。这些发现从功能上将Lck激酶与参与细胞介导的细胞毒性的T细胞效应途径联系起来。